ARCHIVES

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

This article is from The Cancer Letter archive.

Vol. 25 No. 47 | December 10, 1999

Download PDF Visit The Full Archive

Related Articles

In Congress: Senate Committee Approves 15% Increase For NCI In FY 1999; Report Urges NCI To Increase Research In Several Cancers

September 11, 1998

ACCC Annual Meeting Expands to 4 Days, One On Cancer Control

January 15, 1982

In Brief: NCI Seeks Better Ways to Make Available Fresh Tissue; Iverson Heads Cancer Control Science

October 5, 1984

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

February 17, 1984

Cvitkovic Responds To Story On March ODAC Meeting.

June 23, 2000